Draft Study Specifications
==============================

Endpoints:
- Primary endpoint: Survival rate
- Secondary endpoint: Adverse events

Eligibility Criteria:
- Adults 18-65
- No prior chemotherapy

Study Parameters:
- Sample size: 200
- Randomized, double-blind
